(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SAMIL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SAMIL

ST13

US500000097558803

Class

5

Filing

97558803

Registration

7603272

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

12/17/2024

Trademark type

Combined

Nice classes

5

Filing date

08/22/2022

Registration date

12/17/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/17/2024

Last transaction

12/17/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

03

Owner location

Seoul, KR

Examiner

ALLEN, BIANCA

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the underlined word "SAMIL" in cursive writing.

Holders and representatives

Holders

Samil Pharmaceutical Co., Ltd.

Representatives

Arno Naeckel PATENTED PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the prevention and treatment of ophthalmic diseases; pharmaceutical preparations for the treatment of ophthalmic conditions; pharmaceutical preparations for the treatment of brain diseases and disordersepilepsyAlzheimer'scerebral palsyParkinson's diseasemultiple sclerosis; pharmaceutical preparations for the treatment of neurological disordersbrain injuryspinal cord injuryseizure disorders; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorderscrohn's diseaseirritable bowel syndrome; pharmaceutical preparations for the treatment of pain

Publications

History of USPTO decisions and trademark events.

38 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/17/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/17/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/24/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/24/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/24/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/15/2024

PUBO

PUBLISHED FOR OPPOSITION

10/15/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/25/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/09/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/08/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/08/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/23/2024

GNRT

NON-FINAL ACTION E-MAILED

07/23/2024

CNRT

NON-FINAL ACTION WRITTEN

07/23/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/18/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/18/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

07/17/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/16/2024

GNSL

LETTER OF SUSPENSION E-MAILED

04/16/2024

CNSL

SUSPENSION LETTER WRITTEN

04/16/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/16/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/16/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/15/2024

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

01/22/2024

GNSI

INQUIRY TO SUSPENSION E-MAILED

01/22/2024

CNSI

SUSPENSION INQUIRY WRITTEN

01/22/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

01/17/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/15/2023

GNSL

LETTER OF SUSPENSION E-MAILED

06/15/2023

CNSL

SUSPENSION LETTER WRITTEN

06/15/2023

DOCK

ASSIGNED TO EXAMINER

06/08/2023

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

10/07/2022

ALIE

ASSIGNED TO LIE

10/07/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/13/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/10/2022

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

08/29/2022

NWAP

NEW APPLICATION ENTERED

08/25/2022

Continuous trademark protection

Get notified about every new filing that threatens SAMIL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.